ImmunoPrecise Antibodies's market cap is currently $18.45M. The company's EPS TTM is $-0.751; its P/E ratio is ―; ImmunoPrecise Antibodies is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	C$ 24.52M	C$ 20.66M	C$ 19.36M	C$ 17.91M	C$ 14.06M
Gross Profit	C$ 12.05M	C$ 11.56M	C$ 10.98M	C$ 11.54M	C$ 8.03M
Operating Income	C$ -13.76M	C$ -26.09M	C$ -15.78M	C$ -6.65M	C$ -4.09M
EBITDA	C$ -22.95M	C$ -21.04M	C$ -11.99M	C$ -1.42M	C$ -449.00K
Net Income	C$ -27.18M	C$ -26.56M	C$ -16.71M	C$ -7.34M	C$ -4.95M
Balance Sheet
Cash & Short-Term Investments	C$ 3.46M	C$ 8.28M	C$ 29.96M	C$ 41.76M	C$ 2.61M
Total Assets	C$ 59.99M	C$ 77.81M	C$ 93.49M	C$ 66.96M	C$ 27.26M
Total Debt	C$ 13.68M	C$ 7.27M	C$ 2.55M	C$ 3.46M	C$ 4.51M
Net Debt	C$ 10.22M	C$ -1.01M	C$ -27.42M	C$ -38.30M	C$ 1.90M
Total Liabilities	C$ 26.07M	C$ 20.01M	C$ 18.21M	C$ 10.04M	C$ 12.18M
Stockholders' Equity	C$ 33.92M	C$ 57.80M	C$ 75.28M	C$ 56.92M	C$ 15.09M
Cash Flow
Free Cash Flow	C$ -5.64M	C$ -21.33M	C$ -11.18M	C$ -2.03M	C$ -1.97M
Operating Cash Flow	C$ -4.25M	C$ -19.83M	C$ -9.92M	C$ -600.00K	C$ -1.39M
Investing Cash Flow	C$ -1.56M	C$ -1.97M	C$ -5.21M	C$ -2.46M	C$ -1.58M
Financing Cash Flow	C$ 1.02M	C$ -621.00K	C$ 2.88M	C$ 43.38M	C$ 174.70K

Currency in CAD

ImmunoPrecise Antibodies Earnings and Revenue History

Income Statement >

ImmunoPrecise Antibodies Debt to Assets

Balance Sheet >

ImmunoPrecise Antibodies Cash Flow

Cash Flow >

ImmunoPrecise Antibodies Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing